CBD Life Sciences Inc. (CBDL) Announces Groundbreaking 100MG Full Spectrum CBD Gummy Geared Toward Mental Health & Focus

April 22, 2025 8:00 AM

CBD Life Sciences Inc. (OTC PINK:CBDL) a leader in cannabinoid-driven health innovation - proudly announces the launch of its most anticipated product to date: a high-dosage 100MG Full Spectrum CBD Gummy, meticulously formulated to support mental health, daily focus, and emotional well-being.Available in mouth-watering Crisp Green Apple and Wild Blueberry flavors, this isn't your average CBD gummy. It's a next-generation wellness tool - designed...

Read more

Medisafe Launches VIA: AI Voice Tech That Supercharges Patient Engagement and Slashes Enrollment Friction

April 22, 2025 8:00 AM

Medisafe today launched VIA (Voice Intelligent Agent) - a breakthrough AI voice assistant designed to fix pharma's $5B patient support gap and transform how specialty brands activate, engage, and retain patients.It's not a bot. It's a breakthrough. VIA represents a new frontier in AI-powered engagement, built for specialty and complex care. If your brand is struggling with program activation or patient reach, it's time to put a voice to the...

Read more

Avant Brands Announces its Annual General and Special Meeting of Shareholders

April 22, 2025 7:30 AM

Avant Brands Inc. (TSX:AVNT)(OTCQX:AVTBF)(FRA:1BU0) ("Avant" or the "Company"), a leading producer of innovative and award-winning cannabis products, is pleased to announce its upcoming annual general and special meeting (the "Meeting") of the shareholders of the Company (the "Shareholders") to be held on May 30, 2025.The notice of Meeting and the management information circular (the "Circular") will be made available to Shareholders on Avant's...

Read more

Bausch Health Announces Filing of Supplement to Proxy Statement

April 22, 2025 7:25 AM

Bausch Health Companies Inc. (NYSE:BHC)(TSX: BHC) (the "Company" or "Bausch Health") today announced that it has filed a supplement (the "Proxy Statement Supplement") to its proxy statement dated April 2, 2025 (the "Proxy Statement") in respect of the Company's upcoming annual general meeting of shareholders on May 13, 2025. The Company is updating the Proxy Statement to disclose, in addition to the 34,721,118 common shares reported as being...

Read more

Avel eCare Delivers Consistency in Care as Hospitals Face Rising Costs, Chronic Conditions, and Overwhelmed Emergency Rooms

April 22, 2025 7:21 AM

As healthcare systems across the nation confront a perfect storm of rising costs, chronic disease management, staff burnout, and prolonged emergency room wait times, Avel eCare is offering hospitals a lifeline. Avel delivers 24/7 virtual clinical support that enables hospitals to increase patient volume and throughput, without increasing staffing costs, often enabling significant savings.With more than 40% of Critical Access Hospitals (CAHs) at...

Read more

DEA Officials Face Potential Dismissal Under Trump's Schedule F Workforce Reform Plan

April 22, 2025 5:00 AM

President Donald Trump takes steps to reimplement Schedule F, a controversial federal workforce policy designed to reclassify civil servants as at-will employees.Several high-profile officials within the U.S. Drug Enforcement Administration (DEA) could be among those at risk of termination.Among those under scrutiny Thomas Prevoznik, DEA Deputy Administrator; Matthew Strait, DEA Deputy Administrator for Policy and Aarathi Haig, a DEA attorney...

Read more

V&P Scientific Expands Long-Term Partnership With Bioz, Enhancing Product Visibility

April 22, 2025 4:00 AM

Bioz, Inc., a trusted leader in AI-driven research citation solutions, is proud to announce the continued partnership with V&P Scientific, now entering its third year. By renewing its collaboration, V&P Scientific is further leveraging Bioz Badges and a Bioz Content Hub to showcase real-world validation of its innovative laboratory products.Bioz Prime Badges dynamically display peer-reviewed citations directly on V&P Scientific's product...

Read more

Interim Report January-March 2025: 94 Percent Growth

April 22, 2025 2:50 AM

Senzime (STO:SEZI)(OTCQX:SNZZF) - Senzime AB's (publ) interim report for January - March 2025 is now available on the company's website www.senzime.comFinancial information January - March 2025Net sales amounted to TSEK 23,499 KSEK (12,120), a 94 percent increase. Sales of instruments/other were TSEK 9,237 (4,864), a 90 percent increase. Sales of disposables were TSEK 14,262 (7,256), a 97 percent increase.The gross margin excluding amortization...

Read more

From Fatigue to Freedom: How One Shift in Your Health Can Change Your Life with Total Health Revive

April 21, 2025 5:45 PM

Chronic fatigue, brain fog, weight gain, inflammation-these symptoms are becoming alarmingly common in today's fast-paced world. But what if the key to reversing them lies not in more medications or temporary fixes, but in one fundamental shift-reviving your health at the cellular level?This is the life-changing philosophy behind Total Health Revive (THR), a wellness organization rapidly transforming lives across the globe. Founded by Dr. Brian...

Read more

Arden Home Health & Hospice Expands Services in Central MS and the Jackson Metro Area

April 21, 2025 5:00 PM

Arden Home Health & Hospice is proud to announce another major milestone in its continued expansion of services. On March 10, Arden officially announced the expansion of its home health services to Hinds, Rankin, Simpson, Lawrence, and Jefferson Davis counties, extending its commitment to compassionate, high-quality care to more patients and families across Central Mississippi. Also, this expansion means that Arden now provides both home health...

Read more

Electronic Caregiver Surpasses $1.4 Million in Annual Cloud Investment, Cementing Infrastructure Readiness for Global Virtual Care Expansion

April 21, 2025 4:40 PM

Electronic Caregiver (ECG) today announced that it has surpassed $1.4 million annually in cloud and managed services spending across Amazon Web Services (AWS) , Google Cloud Platform (GCP) , Microsoft (primarily Microsoft 365, with additional Azure services via partners), and other essential SaaS and cloud-based platforms including Sage Intacct, Five9, RingCentral, Unity Technologies, Datadog, Adobe Creative Cloud, and specialized...

Read more

Aytu BioPharma to Present at the Planet MicroCap Showcase: VEGAS 2025 on April 23, 2025

April 21, 2025 4:05 PM

Aytu BioPharma, Inc. (the "Company" or "Aytu") (Nasdaq:AYTU), a pharmaceutical company focused on commercializing novel therapeutics, today announced that it will be presenting at the Planet MicroCap Showcase: VEGAS 2025 in partnership with MicroCapClub on Wednesday, April 23, 2025, at 1:30 p.m. Pacific time (4:30 p.m. Eastern time). Josh Disbrow, CEO of Aytu, will be hosting the presentation and answering questions at the conclusion.Planet...

Read more

Aptevo Therapeutics $2.0 Million Registered Direct Offering Priced At-The-Market Under Nasdaq Rules

April 21, 2025 2:40 PM

Aptevo Therapeutics Inc. (Nasdaq:APVO) ("Aptevo" or the "Company"), a clinical-stage biotechnology company focused on developing novel immune-oncology therapeutics based on its proprietary ADAPTIR™ and ADAPTIR-FLEX™ platform technologies, announced today that it has entered into definitive securities purchase agreements for the purchase and sale of 2,324,000 shares of the Company's common stock in a registered direct offering (the "offering") at...

Read more

9 Under-the-Radar AI Innovations Set to Transform Healthcare Revenue Cycle Management- Black Book Research

April 21, 2025 1:30 PM

Artificial intelligence (AI) continues to reshape healthcare, with significant yet lesser-known advancements emerging specifically within Revenue Cycle Management (RCM). Black Book Research's independent study from Q2 2025 surveyed 460 revenue cycle professionals across hospitals, physician groups, diagnostic centers, and long-term care facilities, revealing impactful but under-the-radar AI innovations. These technologies are driving notable...

Read more

Exousia Pro CSO Revealed Significant Findings About the Glioblastoma Study in a Spaces Interview

April 21, 2025 11:45 AM

MARIJUANA INC. (OTC PINK:MAJI), dba Exousia Pro, Inc., a clinical-stage biotech company utilizing exosomes in the treatment of cancer and other diseases, is pleased to share published information about the therapy being used in our current Glioblastoma ("GBM") study.Dr. Marvin Hausman, our Chief Science Officer, revealed Thursday live on a Spaces interview that a paper had been published showing that the NANOG Expression therapy reduced the...

Read more

Behavioral Innovations Appoints Ed Maher as Chief Executive Officer

April 21, 2025 11:00 AM

Behavioral Innovations announces the appointment of Ed Maher as Chief Executive Officer. Maher succeeds Dino Eliopoulos, who has played an instrumental role in the company's growth and success, and will transition into the role of Executive Chairman of the Board of Directors.Ed Maher has been a key part of Behavioral Innovations' leadership team since 2020, serving most recently as President and Chief Operating Officer. In these roles, he has...

Read more

Serve You Rx Named a Top Workplace for the Second Consecutive Year

April 21, 2025 10:00 AM

The Milwaukee Journal Sentinel has awarded Serve You Rx a Top Workplaces honor for the second year. This prestigious recognition is based solely on authentic employee feedback from a third-party survey. Employees are the exclusive decision-makers in determining whether a company culture merits this distinction."Being recognized as a Top Workplace for the second consecutive year reflects our ongoing commitment to fostering a positive environment...

Read more

Small Business Owners Push for Stronger Oversight of Unregulated Caregivers on Web Platforms

April 21, 2025 9:00 AM

In an effort to safeguard vulnerable members of the community, Mike Durkin and Mike Durkin Jr., the father-son team behind ComForCare's home care services in Mercer County, NJ, are meeting with state and federal legislators to raise urgent concerns about the risks posed by unlicensed and unqualified caregivers found through popular online platforms.The Durkins are advocating for tighter regulation and enforcement in the fast-changing in-home...

Read more

Applied DNA's LineaRx Subsidiary Stands Ready to Support the Reshoring of Drug Development and Manufacturing with U.S.-Produced Synthetic DNA

April 21, 2025 9:00 AM

Applied DNA Sciences, Inc. (NASDAQ:APDN) (Applied DNA or the "Company"), a leader in PCR-based DNA technologies, today announced that LineaRx, Inc., the Company's majority-owned subsidiary, has completed a long-term initiative to source critical input materials for its LineaDNA™ and LineaIVT™ platforms from U.S.-based suppliers. The initiative, undertaken in response to the 2024 BIOSECURE Act and customer demand for a U.S.-based supply chain,...

Read more

Clinical Research Associates: Patient Care First

April 21, 2025 9:00 AM

Located in Nashville, Tennessee, Clinical Research Associates, Inc. has been partnering with pharmaceutical and biotechnology companies to research new medications, vaccines, and medical devices for 35 years. This award-winning research center has conducted almost 900 clinical trials to date. And, as the industry consolidates and research sites are being purchased by investors, Clinical Research Associates remains an independently owned private...

Read more